SEC restatements

MoonLake Immunotherapeutics (MLTX)

MoonLake Immunotherapeutics has 9 revised figures in later SEC filings: annual figures whose value in a later filing differs from the value on record first. Each revision below links to both filings.

CIK 0001821586

Annual figures revised
9
Latest filing stating a revision
Mar 20, 2023

Most recent revisions

Newest 3 of 9 · as filed · by the latest filing stating each revision

A revised figure is not by itself a correction of an error. Companies re-present prior figures for ordinary reasons too, such as a discontinued business, a merger or a new accounting standard. The value on record first is the earliest filing we hold that states the figure; the revised value is the latest revised value on record, linked to the latest filing that states it.

9

revised annual figures for MoonLake Immunotherapeutics

This page shows the most recent 3. The complete list, every revised figure with both values and both filings, is in the API and the MCP server (get_revisions) on the Analyst plan.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

Every revised figure for this company, with both values and both filings (Analyst)
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/revisions/MLTX

MCP tool: get_revisions ticker=MLTX

Not investment advice. Figures are shown as filed with the SEC; each one links to the filing it came from.